TBIQYR9085-Global Orally Disintegrating Tablet (ODT) Market Research Report 2019
- TBI886183
- February 18, 2019
- Global
- 102 pages
- QY Market Research
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
The global Orally Disintegrating Tablet (ODT) market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Orally Disintegrating Tablet (ODT) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Orally Disintegrating Tablet (ODT) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Anti-Psychotics Drug
Anti-Epileptics Drug
Other
Segment by Application
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other
Table of Contents
Executive Summary
1 Orally Disintegrating Tablet (ODT) Market Overview
1.1 Product Overview and Scope of Orally Disintegrating Tablet (ODT)
1.2 Orally Disintegrating Tablet (ODT) Segment by Type
1.2.1 Global Orally Disintegrating Tablet (ODT) Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Anti-Psychotics Drug
1.2.3 Anti-Epileptics Drug
1.2.4 Other
1.3 Orally Disintegrating Tablet (ODT) Segment by Application
1.3.1 Orally Disintegrating Tablet (ODT) Consumption Comparison by Application (2014-2025)
1.3.2 CNS Diseases
1.3.3 Gastrointestinal Diseases
1.3.4 CVS Diseases
1.3.5 Other
1.3 Global Orally Disintegrating Tablet (ODT) Market by Region
1.3.1 Global Orally Disintegrating Tablet (ODT) Market Size Region
1.3.2 North America Status and Prospect (2014-2025)
1.3.3 Europe Status and Prospect (2014-2025)
1.3.4 China Status and Prospect (2014-2025)
1.3.5 Japan Status and Prospect (2014-2025)
1.3.6 Southeast Asia Status and Prospect (2014-2025)
1.3.7 India Status and Prospect (2014-2025)
1.4 Global Orally Disintegrating Tablet (ODT) Market Size
1.4.1 Global Orally Disintegrating Tablet (ODT) Revenue (2014-2025)
1.4.2 Global Orally Disintegrating Tablet (ODT) Production (2014-2025)
2 Global Orally Disintegrating Tablet (ODT) Market Competition by Manufacturers
2.1 Global Orally Disintegrating Tablet (ODT) Production Market Share by Manufacturers (2014-2019)
2.2 Global Orally Disintegrating Tablet (ODT) Revenue Share by Manufacturers (2014-2019)
2.3 Global Orally Disintegrating Tablet (ODT) Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Orally Disintegrating Tablet (ODT) Production Sites, Area Served, Product Types
2.5 Orally Disintegrating Tablet (ODT) Market Competitive Situation and Trends
2.5.1 Orally Disintegrating Tablet (ODT) Market Concentration Rate
2.5.2 Orally Disintegrating Tablet (ODT) Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Orally Disintegrating Tablet (ODT) Production Market Share by Regions
3.1 Global Orally Disintegrating Tablet (ODT) Production Market Share by ...
| read more...
Related Reports
